Fig. 1From: A 15-Year Follow-up of AJCC Stage III Malignant Melanoma Patients Treated Postsurgically with Newcastle Disease Virus (NDV) Oncolysate and Determination of Alterations in the CD8 T Cell Repertoire Kaplan-Meier curve demonstrating the 15-year survival of AJCC stage III malignant melanoma patients treated postsurgically with NDV oncolysate. Back to article page